CH Biotech Ser obtains HKEX waiver to delay circular on PHC Medical Diagnostic & Premier Medicare disposal

Bulletin Express

Jun 30

China Biotech Services Holdings Ltd. (CH Biotech Ser) has secured a waiver from Hong Kong Exchanges and Clearing Limited under Rule 19.41(a) of the GEM Listing Rules, allowing additional time to despatch the shareholder circular related to its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Ltd. and Premier Medicare Services Ltd.

The waiver follows earlier announcements on 18 May 2026 and 2 June 2026 that outlined the major transaction, as well as subsequent notices on 9 June 2026 and 26 June 2026 that flagged delays in preparing the circular. According to the latest announcement dated 29 June 2026, the circular must now be despatched on or before 10 July 2026.

The company cited the need for more time to finalise information for inclusion in the document as the primary reason for the extension request. The Stock Exchange granted the waiver on the condition that the revised deadline is met.

The board of CH Biotech Ser currently comprises six directors: three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.

The announcement reiterates that the directors accept full responsibility for the accuracy and completeness of the disclosed information.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1135338590"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1135338590\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1135338590?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-30 07:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1135338590","market":"hk","top_or_hot":-1,"title":"CH Biotech Ser obtains HKEX waiver to delay circular on PHC Medical Diagnostic & Premier Medicare disposal","media":"Bulletin Express","content":"<p>China Biotech Services Holdings Ltd. (CH Biotech Ser) has secured a waiver from Hong Kong Exchanges and Clearing Limited under Rule 19.41(a) of the GEM Listing Rules, allowing additional time to despatch the shareholder circular related to its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Ltd. and Premier Medicare Services Ltd.</p>\n<p>The waiver follows earlier announcements on 18 May 2026 and 2 June 2026 that outlined the major transaction, as well as subsequent notices on 9 June 2026 and 26 June 2026 that flagged delays in preparing the circular. According to the latest announcement dated 29 June 2026, the circular must now be despatched on or before 10 July 2026.</p>\n<p>The company cited the need for more time to finalise information for inclusion in the document as the primary reason for the extension request. The Stock Exchange granted the waiver on the condition that the revised deadline is met.</p>\n<p>The board of CH Biotech Ser currently comprises six directors: three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.</p>\n<p>The announcement reiterates that the directors accept full responsibility for the accuracy and completeness of the disclosed information.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CH Biotech Ser obtains HKEX waiver to delay circular on PHC Medical Diagnostic & Premier Medicare disposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCH Biotech Ser obtains HKEX waiver to delay circular on PHC Medical Diagnostic & Premier Medicare disposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-30 07:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Biotech Services Holdings Ltd. (CH Biotech Ser) has secured a waiver from Hong Kong Exchanges and Clearing Limited under Rule 19.41(a) of the GEM Listing Rules, allowing additional time to despatch the shareholder circular related to its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Ltd. and Premier Medicare Services Ltd.</p>\n<p>The waiver follows earlier announcements on 18 May 2026 and 2 June 2026 that outlined the major transaction, as well as subsequent notices on 9 June 2026 and 26 June 2026 that flagged delays in preparing the circular. According to the latest announcement dated 29 June 2026, the circular must now be despatched on or before 10 July 2026.</p>\n<p>The company cited the need for more time to finalise information for inclusion in the document as the primary reason for the extension request. The Stock Exchange granted the waiver on the condition that the revised deadline is met.</p>\n<p>The board of CH Biotech Ser currently comprises six directors: three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.</p>\n<p>The announcement reiterates that the directors accept full responsibility for the accuracy and completeness of the disclosed information.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"08037","symbol_name":"中国生物科技服务","start_time":0,"source_url":"","article_id":"1135338590","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1135338590","pubTimestamp":1782774223,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Biotech Services Holdings Ltd. (CH Biotech Ser) has secured a waiver from Hong Kong Exchanges and Clearing Limited under Rule 19.41(a) of the GEM Listing Rules, allowing additional time to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"08037":"中国生物科技服务"},"translate_title":"CH Biotech Ser获得港交所豁免延迟有关PHC Medical Diagnostic及Premier Medicare处置的通函","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08037":1},"content_text":"China Biotech Services Holdings Ltd. (CH Biotech Ser) has secured a waiver from Hong Kong Exchanges and Clearing Limited under Rule 19.41(a) of the GEM Listing Rules, allowing additional time to despatch the shareholder circular related to its proposed disposal of the entire issued share capital in PHC Medical Diagnostic Centre Ltd. and Premier Medicare Services Ltd.\nThe waiver follows earlier announcements on 18 May 2026 and 2 June 2026 that outlined the major transaction, as well as subsequent notices on 9 June 2026 and 26 June 2026 that flagged delays in preparing the circular. According to the latest announcement dated 29 June 2026, the circular must now be despatched on or before 10 July 2026.\nThe company cited the need for more time to finalise information for inclusion in the document as the primary reason for the extension request. The Stock Exchange granted the waiver on the condition that the revised deadline is met.\nThe board of CH Biotech Ser currently comprises six directors: three executive directors—Chairman Liu Xiaolin, Dr. Huang Song and Dr. Yin Ye—and three independent non-executive directors—Mr. Yan Guoxiang, Dr. Guo Yuantao and Dr. Zhang Xiao.\nThe announcement reiterates that the directors accept full responsibility for the accuracy and completeness of the disclosed information.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}